Search by Drug Name or NDC
NDC 65862-0454-71 Alprazolam 0.5 mg/1 Details
Alprazolam 0.5 mg/1
Alprazolam is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is ALPRAZOLAM.
MedlinePlus Drug Summary
Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.
Related Packages: 65862-0454-71Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Alprazolam
Product Information
| NDC | 65862-0454 |
|---|---|
| Product ID | 65862-454_770e31e7-2444-4748-b0aa-f0b1981664e3 |
| Associated GPIs | 57100010007505 |
| GCN Sequence Number | 050399 |
| GCN Sequence Number Description | alprazolam TAB ER 24H 0.5 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 17423 |
| HICL Sequence Number | 001617 |
| HICL Sequence Number Description | ALPRAZOLAM |
| Brand/Generic | Generic |
| Proprietary Name | Alprazolam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Alprazolam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | ALPRAZOLAM |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA090871 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65862-0454-71 (65862045471)
| NDC Package Code | 65862-454-71 |
|---|---|
| Billing NDC | 65862045471 |
| Package | 7000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-454-71) |
| Marketing Start Date | 2011-06-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |